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How important is blindness? Is being blind 17%(1) or 60%(2, 3) as bad as being 
dead? More importantly, why is there such disagreement?  
 
These numbers are from disability weights. They were introduced by the Global 
Burden of Disease (GBD) Study (1990) to give a new population health measure, the 
disability adjusted life year (DALY).(2) DALYs aimed to capture a societal assessment 
of the burden of disease resulting from premature mortality and the non-fatal 
consequences of disease and injury.(2) Their concern was for social justice and the 
association between the health states resulting from disease, and lost welfare, 
subjective wellbeing and quality of life.(2) DALYs differed from quality adjusted life 
years (QALYs), which measure individual preferences for time spent in different 
health states.(4) DALYs aimed to facilitate a more explicit and consistent comparison 
of health outcomes for health sector evaluation, and resource allocation.  
 
DALYs are the sum of years of life lost (YLL) due to premature mortality and years 
lived with disability (YLD). Calculation of the latter includes the disability weight – a 
number on a scale from 0 to 1.0. A weight close to zero indicates a state of minimal 
impact, whilst a weight close to 1.0 indicates a state so severe its impact is almost 
as bad as death. Disability weights are obtained from ordinal measurement of 
preferences (paired health state comparisons). Advanced modeling transforms these 
data into weights. To date, eight studies have estimated disability weights for 
blindness (Table 1),(5) using different approaches.(1-3, 6-10). These weights vary 
from 0.60 in the original GBD study to 0.19 in the 2010 GBD study. This 3-fold 
reduction in the recent GBD disability weight reduces the apparent importance of 
cataract blindness(11, 12), questioning the validity of the disability weights. Applying 
the weights from the original and 2010 GBD studies gives very different estimates of 
the effectiveness of cataract surgery: In one study, from 2599 DALYs averted 
(disability weight 0.60 for blindness) to just 156 DALYs averted (disability weight 
0.033 for moderate distance vision impairment).(13)  
 
There are a number of possible explanations for the discrepancy. In our opinion, the 
most significant is the change from rating “disability” to rating “health”. Health, as 
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conceptualised by the World Health Organisation (WHO), is a multidimensional 
construct, defined as, “a state of complete physical, mental and social well-being 
and not merely the absence of disease or infirmity.” In the original GBD Study six 
weights captured „loss of wellbeing‟; blindness was assigned a weight of 0.60.(2) 
These were defined in reference to limitations in ability to perform activities of 
procreation, occupation, education and recreation or needing assistance with 
activities of daily living. Fundamentally this is the measurement of disability. In 
contrast, the recent GBD Studies(9, 10) framed questions about „loss of health‟. 
Although this resulted in only small changes to the disability weights for most 
disease states, for disabling conditions, including vision and hearing loss, the 
reduction was dramatic, attributed by some to the change in construct (14, 15).  
This is not surprising; blind people often say, “I am not sick, I just can‟t see!” 
 
A second factor is variability in the description of different effects of the “disease”. 
The original GBD Study (1990) defined blindness as, “maximal visual acuity of less 
than 3/60 with the best possible correction,” resulting in, “limited ability to perform 
most activities in all of the following areas: recreation, education, procreation or 
occupation.”(3) The recent GBD studies defined blindness as, “completely blind, 
which causes great difficulty in some daily activities, worry and anxiety, and great 
difficulty going outside the home without assistance.” (See Table 2)(9, 10) After 
criticism of some of the GBD 2010 disability weights, including those for vision 
loss,(14)(15) the GBD 2013 study tested a revised lay definition for some conditions. 
For example, the revised definition for deafness included a more explicit description 
of social isolation. When retested, the weight changed dramatically from 0.09 to 
0.32, leading to the conclusion that, “in some cases, responses are evidently highly 
sensitive to particular details in these descriptions”.(10) The definition for blindness 
was not modified in the GBD 2013 study and the weight changed negligibly, from 
0.195 to 0.187, in comparison to that reported in the GBD 2010 study.(9, 10) 
 
A third factor for the variability in disability weights may be the way questions were 
asked in different studies. Comparing two health problems with different limitations 
requires complex judgment about which characteristics are more important.(10, 14) 
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The recent GBD studies asked who, of two hypothetical people, was „healthier‟ (See 
Table 2).(9, 10) A definition was given at the start, but not repeated for each of the 
14 paired comparisons, so respondents may not have retained the intended 
definition of „health‟ all the way through.(14)  
 
A fourth factor may be differences in the respondents in different studies. The 
original GBD study used medical or health experts. Others, including the recent GBD 
studies, used members of the general public, with no expectation of understanding 
of health conditions, who may not have been population-representative.  
 
A fifth factor may be the different valuation methods used; paired comparison, 
population health equivalence, person trade off, or a visual analogue scale. The 
potential impact of these different approaches is unknown. To add further potential 
confusion, the DALY itself is not a single measure, but combines YLL and YLD, which 
may vary with different combinations of data on prevalence, incidence, and life 
expectancy,(16) adding complexity when comparing conclusions from different 
studies.(16, 17) 
 
The downgrading of the disability weight for blindness has considerable 
consequences. Over the past two decades both the disability weight and the DALY 
have gained credence as important advocacy tools to highlight the burden and 
impact of disease at a population level. DALYs and QALYs have been used in 825 
national studies to demonstrate that surgical interventions are cost-effective global 
priorities.(18) Disability weights have been used to estimate the potential global 
productivity loss associated with uncorrected refractive error,(19) and with 
uncorrected presbyopia.(20) Multiple organisations advocate „DALYs averted‟ as 
bottom-line performance metrics for guiding strategic and resource prioritisation 
decisions in relation to competing public health interventions.(21, 22)  
 
In the ranking of the global burden of DALYs by cause, the recent GBD Studies 
ranked cataract and other blinding eye diseases much lower than in the original GBD 
study,(23) sparking controversial debate, even between the GBD Core and Vision 
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Loss Expert Groups.(15, 24) The ophthalmic community has been left in a state of 
understandable confusion. Which summary outcome measure should be preferred 
for advocacy, benchmarking and resource allocation decisions at the population 
level? If the DALY is a useful metric, which disability weight should be used to 
calculate it?  
 
The WHO has not endorsed the recent GBD disability weight for blindness, given the 
significant and unexpected reduction in its value, and proposes an alternative weight 
of 0.338 obtained from modeling utility data.(25) Understanding the context of 
deriving disability weights is important, as is recognising that the recent weight for 
blindness, 0.19, represents a valuation of health loss rather than disability.(26) 
Further empirical research is needed to better understand societal valuations of 
blindness, by isolating the impact of what questions are asked and how, and through 
ensuring conceptual clarity on the key construct under investigation (is it disability or 
is it health?).  
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TABLES 
 
Table 1: Summary of studies estimating a disability weight for blindness 
 
First author Year Region Panel n panel n 
health 
states 
Valuation 
methods 
DW (95% 
CI) 
Construct 
in the 
question 
Murray(2) 1994 Global Independent 
experts 
NS 6 Magnitude 
estimation 
0.6 Disability  
Murray GBD 
1990(3)  
1996 Global Medical 
experts 
10 483 PTO and 
VAS 
0.6 (0.50 – 
0.70) 
Disability 
Stouthard (6) 1997 Netherlands Medical 
experts 
38 175 PTO and 
VAS 
0.43 (0.34 -
0.52) 
Disability 
Baltussen (7) 2002 Burkina 
Fasso 
Health 
professionals, 
Population 
39 lay 
people, 
17 
health 
workers 
9 Culturally 
adapted VAS 
0.36 Disability 
Lai (8) 2009 Estonia Medical 
experts 
25 283 PTO and 
VAS 
0.478 Disability 
Salomon GBD 
2010 (9) 
2012 Global Population-
based 
samples 
30,230 220 PC and PHE 0.195 
(0.132-
0.272)  
Health loss 
Haagsma 
GBD Europe 
(1) 
2015 Europe (4): 
Sweden, 
Italy, 
Netherlands, 
Hungary 
Population 
(quota 
sampling of 
internet 
panels, 
population 
representative
, 18-65 years) 
30,660 255 PC and PHE 0.173 (0.145 
-0.213) 
Health loss 
Salomon GBD 
2013 (10) 
2015 Global Population 
(combined 
data)(7, 8) 
60,890 183 or 
235 
PC 0.187 (0.124 
- 0.260) 
 
Health loss 
 
GBD = Global Burden of Disease, PC = Paired comparison, NS= Not specified, 
PTO=person trade off, VAS=visual analog scale, PHE = Population Health 
Equivalence   
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Table 2: Example of paired comparison question used in GBD 2013 Study(10) to 
determine a disability weight for two disease effects, distance vision blindness and 
severe neck pain 
 
Example of GBD 2013 Paired comparison question GBD 2013 disease 
effect and disability 
weight 
“Now, we want to learn how people compare different health 
problems.  
A person‟s health may limit how well parts of his body or his mind 
works. As a result, some people are not able to do all of the things in 
life that others may do, and some people are more severely limited 
than others. I am going to ask you a [series of] question[s] about 
different health problems. In each question I will describe two 
different people to you. You should image that these two people have 
the same number of years left to live, and that they will experience 
the health problems that I describe for the rest of their lives. I will ask 
you to tell me which person you think is healthier overall, in terms of 
having fewer physical or mental limitations on what they can do in life. 
Some of the questions may be easy to answer, while others may be 
harder. There are no right or wrong answers to these questions. 
Instead we are interested in finding out your personal views.  
 
 
The first person is completely blind, which causes great difficulty in 
some daily activities, worry and anxiety, and great difficulty going 
outside the home without assistance 
 
Distance vision blindness 
0.187 (0.124-0.260) 
The second person has constant neck pain and arm pain, and difficulty 
turning the head, holding arms up, and lifting things. The person gets 
headaches, sleeps poorly, and feels tired and worried 
 
Severe neck pain 
0.304 (0.202-0.415) 
Who do you think is healthier overall, the first person or the second 
person?” 
 
 
 
 
 
 
 
